
News|Articles|June 1, 2002
- Pharmaceutical Technology-06-02-2002
- Volume 26
- Issue 6
Drug Shortages Reveal GMP Concerns
Author(s)Jill Wechsler
FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.
Advertisement
Articles in this issue
over 23 years ago
Excipient GMP Quality Standards: One is Enoughover 23 years ago
The IPEC-Americas Excipient Master File Guideover 23 years ago
Technology Advances Anticounterfeiting Optionsover 23 years ago
Calibration of Lyophilization Pressure Gaugesover 23 years ago
Outsourcing Outlookover 23 years ago
Optimizing Cross-Organizational Team Performance and Managementover 23 years ago
Screening for Counterfeit Drugs Using Near-Infrared Spectroscopyover 23 years ago
Building on Tradition: Integrating the Links of ExpertiseNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
How Codexis is Redefining Pharma Biocatalysis
5




